Sutro Biopharma (STRO) Cash & Equivalents (2017 - 2026)
Sutro Biopharma's Cash & Equivalents was $54.34 million in Q2 2026, down 15.1% from $64.03 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Sutro Biopharma came in at $58.13 million, down 69.5% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -22.4% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $190.3 million in FY2024 (+174.7%), $69.27 million in FY2023 (+46.6%), $47.25 million in FY2022 (+55.4%) and $30.41 million in FY2021 (-85.2%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q4 2022.
- Compared with a year earlier, Cash & Equivalents was higher in three of the last seven quarters, with growth averaging 24.9%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2022 (growth of 215.2%); the worst was Q4 2021 (a decline of 85.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Sutro Biopharma | 267.04 Mn | -411.46 Mn | - | 54.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.34 Mn |
| Dec 31, 2025 | 58.13 Mn |
| Sep 30, 2025 | 65.93 Mn |
| Jun 30, 2025 | 64.03 Mn |
| Mar 31, 2025 | 106.23 Mn |
| Dec 31, 2024 | 190.30 Mn |
| Sep 30, 2024 | 174.58 Mn |
| Jun 30, 2024 | 90.79 Mn |
| Mar 31, 2024 | 65.22 Mn |
| Dec 31, 2023 | 69.27 Mn |
| Sep 30, 2023 | 81.83 Mn |
| Jun 30, 2023 | 235.10 Mn |
| Mar 31, 2023 | 62.47 Mn |
| Dec 31, 2022 | 47.25 Mn |
| Sep 30, 2022 | 96.78 Mn |
| Jun 30, 2022 | 79.12 Mn |
| Mar 31, 2022 | 28.90 Mn |
| Dec 31, 2021 | 30.41 Mn |
| Sep 30, 2021 | 30.71 Mn |
| Jun 30, 2021 | 56.39 Mn |
API Access
Sutro Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();